Publication | Closed Access

O057 : Long-term follow-up of treatment-emergent resistance-associated variants in NS3, NS5A and NS5B with paritaprevir/r-, ombitasvir- and dasabuvir-based regimens

Treatment-emergent Resistance-associated VariantsPathogenesisAntiviral Drug DevelopmentAntiviral TherapyResistance Mutation (Virology)VirologyDasabuvir-based RegimensPharmacotherapyAntiviral DrugMedicineLong-term Follow-upTreatment ResistanceAntimicrobial ResistanceDrug Resistance